Clinical nuclear medicine · 2011
ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Henkin Robert E, Del Rowe John D, Grigsby Perry W, Hartford Alan C, Jadvar Hossein, Macklis Roger M, Parker J Anthony, Wong Jeffrey Y C, Rosenthal Seth A
Аннотация
This guideline is intended to guide appropriately trained and licensed physicians performing therapy with unsealed radiopharmaceutical sources. Adherence to this guideline should help to maximize the efficacious use of these procedures, maintain safe conditions, and ensure compliance with applicable regulations. The topics dealt with in this guideline include indications for the use of iodine-131, both for the treatment of hyperthyroidism and thyroid carcinoma. In addition, indications for other less common procedures include those for the use of phosphorous-32 in its liquid and colloidal forms, strontium-89, samarium-153, and the use of Y-90 antibodies.
Предметные рубрики MeSH
Ablation TechniquesAscitesBone NeoplasmsChemotherapy, AdjuvantDocumentationFemaleFollow-Up StudiesHumansHyperthyroidismInfection ControlLymphoma, Non-HodgkinOvarian NeoplasmsPainPatient Education as TopicPleural EffusionPolycythemia VeraPostoperative PeriodQuality ControlRadiation OncologyRadioimmunotherapyRadiopharmaceuticalsRadiotherapySafetySocieties, MedicalThrombocytosisThyroid Neoplasms